Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Discover Zero Based Budgeting made simple with clear steps to plan, track, and optimize every dollar for better financial health.
20,930 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
When housing activity ebbs, flooring companies face a turning point. This article explores how a leading flooring com...
Warren Buffett's move into a big oil stock has investors buzzing. We break down what this means for long-term fans of...
Paysign's 2025 earnings paint a picture of a niche fintech player balancing steady card-services revenue with new par...
Nvidia’s valuation move is drawing attention from investors weighing AI demand against broader market momentum. This ...
A pivotal week looms as the Federal Reserve eyes its next move. This guide breaks down what a policy shift could mean...
Regulators press to bring call centers onshore to curb fraud, but AI-driven scams are accelerating faster than policy...
Evolv Technologies stock plummeted after mixed results that still beat on revenue and nudged full-year guidance highe...
A sharp move in bicara stock 50% has spotlighted a bold biotech bet that now accounts for nearly a third of one inves...
When a well-known investment advisor unloads a large slice of a stock, it sparks questions. This guide breaks down wh...
Nordson (NDSN) is set for a pivotal 2025 earnings year. This guide breaks down the levers that could move profits, ho...
GTS Securities recently sold a large chunk of its XOVR exposure, shedding about 19.46 million shares worth roughly 35...